BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22142194)

  • 1. Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.
    Ray P; Lewin SA; Mihalko LA; Lesher-Perez SC; Takayama S; Luker KE; Luker GD
    Biochem J; 2012 Mar; 442(2):433-42. PubMed ID: 22142194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.
    Luker K; Gupta M; Luker G
    Biotechniques; 2009 Jul; 47(1):625-32. PubMed ID: 19594447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
    Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
    Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging ligand-dependent activation of CXCR7.
    Luker KE; Gupta M; Steele JM; Foerster BR; Luker GD
    Neoplasia; 2009 Oct; 11(10):1022-35. PubMed ID: 19794961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
    Ray P; Lewin SA; Mihalko LA; Schmidt BT; Luker KE; Luker GD
    Neoplasia; 2011 Dec; 13(12):1152-61. PubMed ID: 22241961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging chemokine receptor dimerization with firefly luciferase complementation.
    Luker KE; Gupta M; Luker GD
    FASEB J; 2009 Mar; 23(3):823-34. PubMed ID: 19001056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Color Luciferase Complementation for Chemokine Receptor Signaling.
    Luker KE; Luker GD
    Methods Enzymol; 2016; 570():119-29. PubMed ID: 26921944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.
    Coggins NL; Trakimas D; Chang SL; Ehrlich A; Ray P; Luker KE; Linderman JJ; Luker GD
    PLoS One; 2014; 9(6):e98328. PubMed ID: 24896823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
    Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
    J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
    Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
    Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
    Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.
    Luker KE; Mihalko LA; Schmidt BT; Lewin SA; Ray P; Shcherbo D; Chudakov DM; Luker GD
    Nat Med; 2011 Dec; 18(1):172-7. PubMed ID: 22138753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
    Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
    J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7.
    Ehrlich A; Ray P; Luker KE; Lolis EJ; Luker GD
    Biochem Pharmacol; 2013 Nov; 86(9):1263-71. PubMed ID: 23973527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
    Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
    Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
    Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia.
    Lipfert J; Ödemis V; Wagner DC; Boltze J; Engele J
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):667-80. PubMed ID: 23289420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.